Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 100 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - incobotulinumtoxina, quantity: 50 u - injection, powder for - excipient ingredients: albumin; sucrose - xeomin is indicated in adults for the treatment of:,? cervical dystonia (spasmodic torticollis),? blepharospasm,? spasticity of the upper limb,? chronic sialorrhea due to neurological disorders,? upper facial lines,- glabellar frown lines,- lateral periorbital lines (crow?s feet),- horizontal forehead lines,xeomin is indicated in children and adolescents aged 2 years to 17 years for the symptomatic treatment of:,? chronic sialorrhea due to neurological/neurodevelopmental disorders,? spasticity of the lower and/or upper limbs

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - 17876 - tissue reconstructive material, synthetic, fluid - radiesse injectable implant is a steam sterilised, semi-solid implant created by suspending calcium hydroxylapatite in a gel carrier consisting primarily of sterile water for injection (usp) and glycerin (usp). the gel structure is formed by adding sodium carboxymethylcellulose (usp). the gel dissipates in vivo, replaced with soft tissue growth, while the calcium hydroxylapatite remains at the injection site. the result is long-term yet non-permanent restoration and augmentation. radiesse injectable implant (part number 8071m19) is indicated for plastic and reconstructive surgery, including deep dermal and sub dermal soft tissue augmentation of the facial area, and is also intended for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus.

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd - 62574 - dermal tissue reconstructive material, synthetic mineral, anaesthetic - radiesse (+) lidocaine injectable implant is a sterile semi solid implant of suspended synthetic calcium hydroxylapatite in a gel carrier of sterile water for injection, glycerin, sodium carboxymethylcellulose, and 0.3% lidocaine. the gel is dissipated in vivo and replaced with soft tissue growth, while the calcium hydroxylapatite remains at the site of injection. pack contains 1 sterile 0.8ml or 1.5ml syringe and 2 sterile 27g 0.75" needles. radiesse (+) lidocaine injectable implant is indicated for plastic / reconstructive procedures, including deep dermal and subdermal soft tissue augmentation of the facial area and is also intended for restoration and correction of fat or volume loss (lipoatrophy) in the facial area and for rejuvenation of the hands.

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -

Australia - English - Department of Health (Therapeutic Goods Administration)

merz australia pty ltd -